PPHM Sep 22 2012 2.5 Put @0.45 Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and infectious diseases. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara. (Take-over candidate?) http://www.melodika.net/index.php?option=com_content&task=view&id=363236&Itemid=54
Market Data 
Markets 
AI
